Essential thrombocythemia or chronic idiopathic myelofibrosis? A single-center study based on hematopoieticbone marrow histology

References

• Murphy S, Iland H, Rosenthal D, Laszlo J. Essential thrombocythaemia: an interim report from the Polycythaemia Vera Study Group. Semin Hematol 1986; 23: 177–182
   PubMed Web of Science ®Google Scholar
• Murphy S, Peterson P, Iland H, Laszlo J. Experience of the Polycythaemia Vera Study group with essential thrombocythaemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment. Semin Hematol 1997; 34: 29–39
   PubMed Web of Science ®Google Scholar
• Tefferi A, Murphy S. Current opinion in essential thrombocythaemia: pathogenesis, diagnosis, and management. Blood Rev 2001; 15: 121–131
   PubMed Web of Science ®Google Scholar
• Thiele J, Schneider G, Hoeppner B, Wienhold S, Zankovich R, Fischer R. Histomorphometry of bone marrow biopsies in chronic myeloproliferative disorders with associated thrombocytosis-features of significance for the diagnosis of primary (essential) thrombocythaemia. Virchows Arch A Pathol Anat Histopathol 1988; 413: 407–417
   PubMedGoogle Scholar
• Georgii A, Vykoupil K F, Buhr T, Choritz H, Dohler U, Kaloutsi V, et al. Chronic myeloproliferative disorders in bone marrow biopsies. Pathol Res Pract 1990; 186: 3–27
   PubMed Web of Science ®Google Scholar
• Georgii A, Buhr T, Buesche G, Kreft A, Choritz H. Classification and staging of Ph-negative myeloproliferative disorders by histopathology from bone marrow biopsies. Leuk Lymphoma 1996; 22(Suppl 1)15–29
   PubMed Web of Science ®Google Scholar
• Thiele J, Kvasnicka H M, Zankovich R, Diehl V. Relevance of bone marrow features in the differential diagnosis between essential thrombocythaemia and early stage idiopathic myelofibrosis. Haematologica 2000; 85: 1126–1134
   PubMed Web of Science ®Google Scholar
• Michiels J J, Thiele J. Clinical and pathological criteria for the diagnosis of essential thrombocythaemia, polycythaemia vera, and idiophatic myelofibrosis (angiogenic myeloid metaplasia). Int J Hematol 2002; 76: 133–145
   PubMed Web of Science ®Google Scholar
• Annaloro C, Lambertenghi Deliliers G, Oriani A, Pozzoli E, Lambertenghi Deliliers D, Radaelli F, et al. Prognostic significance of bone marrow biopsy in essential thrombocythaemia. Haematologica 1999; 84: 17–21
   PubMed Web of Science ®Google Scholar
• Vardiman J W, Brunning R D, Harris N L. Chronic myeloproliferative diseases. WHO Classification of Tumours. Tumours of Haematopoietic and Lymphoid Tissues, E S Jaffe, N L Harris, H Stein, J W Vardiman. IARC Press, Lyon 2001; 39–41
   Google Scholar
• Thiele J, Kvasnicka H M, Boeltken B, Zankovich R, Diehl V, Fischer R. Initial (prefibrotic) stages of idiopathic (primary) myelofybrosis (IMF). A clinicopathological study. Leukemia 1999; 13: 1741–1748
   PubMed Web of Science ®Google Scholar
• Thiele J, Kvasnicka H M, Schmitt-Graeff A, Zankovich R, Diehl V. Follow-up examinations including sequential bone marrow biopsies in essential thrombocythaemia (ET): a retrospective clinicopathological study of 120 patients. Am J Hematol 2002; 70: 283–291
   PubMed Web of Science ®Google Scholar
• Thiele J, Kvasnicka H M. Chronic myeloproliferative disorders with thrombocythaemia: a comparative study of two classification systems (PVSG, WHO) on 839 patients. Ann Hematol 2003; 82: 148–152
   PubMed Web of Science ®Google Scholar
• Florena A M, Tripodo C, Iannitto E, Porcasi R, Ingrao S, Franco V. Value of bone marrow biopsy in the diagnosis of essential thrombocythaemia. Haematologica 2004; 89: 911–919
   PubMed Web of Science ®Google Scholar
• Kreft A, Buche G, Ghalibafian M, Buhr T, Fischer T, Kirkpatrick C J. The incidence of myelofibrosis in essential thrombocythaemia, polycythaemia vera and chronic idiopatic myelofibrosis: a retrospective evaluation of sequential bone marrow biopsies. Acta Haematol 2005; 113: 137–143
   PubMed Web of Science ®Google Scholar
• Thiele J, Kvasnicka H M, Facchetti F, Franco V, Van der Walt J, Orazi A. European consensus for grading of bone marrow fibrosis and assessment of cellularity. Haematologica 2005; 98: 1128–1132
   Google Scholar
• Thiele J, Kvasnicka H M. Diagnostic differentiation of essential thrombocythaemia from thrombocythaemias associated with chronic idiopathic myelofibrosis by discriminate analysis of bone marrow features – a clinicopathological study on 272 patients. Histol Histopathol 2003; 18: 93–102
   PubMed Web of Science ®Google Scholar
• Barbui T, Barosi G, Grossi A, Gugliotta L, Liberato L N, Marchetti M, et al. Practice guidelines for the therapy of essential thrombocythaemia. A statement from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation. Haematologica 2004; 89: 215–232
   PubMed Web of Science ®Google Scholar
• Cortes J, Ault P, Koller C, Thomas D, Ferrajoli A, Wierda W, et al. Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndrome. Blood 2003; 101: 4714–4716
   PubMed Web of Science ®Google Scholar
• Marchetti M, Barosi G, Balestri F, Viarengo G, Gentili S, Barulli S, et al. Low-dose thalidomide ameliorates cytopenias and splenomegaly in myelofibrosis with myeloid metaplasia: a phase II trial. J Clin Oncol 2004; 22: 424–431
   PubMed Web of Science ®Google Scholar
• Faoro L N, Tefferi A, Mesa R A. Long-term analysis of the palliative benefit of 2-chlorodeoxyadenosine for myelofibrosis with myeloid metaplasia. Eur J Haematol 2005; 74: 117–120
   PubMed Web of Science ®Google Scholar
• Barosi G, Ambrosetti A, Finelli C, Grossi A, Leoni P, Liberato N L, et al. The Italian consensus conference on diagnostic criteria for myelofibrosis with myeloid metaplasia. Br J Haematol 1999; 104: 730–737
   PubMed Web of Science ®Google Scholar
• Thiele J, Kvasnicka H M, Diehl V. Initial (latent) polycythaemia vera with thrombocytosis mimicking essential thrombocythaemia. Acta Haematol 2005; 113: 213–219
   PubMed Web of Science ®Google Scholar
• Thiele J, Kvasnicka H M, Diehl V. Standardization of bone marrow features – does it work in hematopathology for histological discrimination of different disease patterns?. Histol Histopathol 2005; 20: 633–644
   PubMed Web of Science ®Google Scholar